is part of the Global Exhibitions Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
As the global leader in implantable hearing solutions, Cochlear is dedicated to bringing the gift of sound to people with moderate to profound hearing loss. We have helped over 450,000 people of all ages live full and active lives by reconnecting them with family, friends and community. We aim to give our recipients the best lifelong hearing experience and access to innovative future technologies. For our professional partners, we offer the industry’s largest clinical, research and support networks. That’s why more people choose Cochlear than any other hearing implant company.
MED-EL is a family-owned pioneering provider of hearing implant solutions, and the leader in the region. The company was founded by Dr. Ingeborg and Prof. Dr. Erwin Hochmair, and is the inventor of the cochlear implant in the form in which it is known today.MED-EL established its presence in the Middle East and North Africa market in the early 1990’s, and continues to reaffirm its commitment to overcoming hearing loss as a barrier to communication through researching, investing in and consequently offering the widest range of solutions to treat various types and degrees of hearing loss.In 2017, MED-EL expanded its cutting edge hearing solutions to include ADHEAR, a new innovative technology offering a non-surgical solution for conductive hearing loss.Most recently, MED-EL introduced RONDO 2, the world’s first cochlear implant audio processor to feature wireless charging. Utilizing a ground-breaking design, the RONDO 2 is easy to use, more cost effective and friendlier to the environment.
As a global leader in medical technology, services and solutions, Medtronic improves the lives and health of millions of people each year. We use our deep clinical, therapeutic and economic expertise to address the complex challenges faced by healthcare systems today. Let’s take healthcare Further, Together. Learn more at Medtronic.com.
KARL STORZ offers the complete package for the ENT practitioner; from rigid endoscopes to flexible fiberscopes and close to 6,000 different instruments. The product range has been topped off with a portfolio of strategic products: the KARL STORZ NAV1 Navigation System, UNIDRIVE SIII Motor System, TIPCAM1 S 3D 4mm telescope, IMAGE1 S Full HD Imaging Systems, and the VITOM® 3D exoscope; the revolutionary solution for the visualization of microsurgical and open surgical interventions in 3D.
As a worldwide leading manufacturer of optical and digital precision technology, Olympus provides innovative solutions for state-of-the-art medical systems, digital cameras and scientific solutions. Olympus is proud to be a gold sponsor at ME-OTO 2018 this year. Amongst others, we will be showcasing the new Celon method, a highly efficient solution for minimally invasive and impedance-controlled tissue ablation. It is extremely user-friendly as its innovative bipolar technique enables safe, gentle, and fast energy transmission into the tissue. In addition, the CELON method requires only a short training session and can generally be performed on an outpatient basis.
Founded 40 years ago, by the late Mr Samih Darwazah, our former Chairman and CEO, our purpose has always been to provide high quality, affordable medicines to the people who need them. Based on the solid foundation we have built, we will continue to innovate and find practical solutions to transform the lives of millions of people we serve. We built our presence in the MENA and established the first FDA-approved manufacturing facility in the region.
Smith & Nephew supports healthcare professionals for more than 160 years, in more than 100 countries in their daily efforts to improve the lives of their patients. We do this by taking a pioneering approach to the design of our advanced medical products and services, by securing wider access to our diverse technologies for more customers globally, and by enabling better outcomes for patients and healthcare systems.